Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a VR headset replace the 6-Minute walk test for diabetes patients?

NCT ID NCT07649967

Knowledge-focused Sponsor: Selcuk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether mixed reality (using a Meta Quest 3 headset) can reliably measure walking ability, balance, and leg strength in people with type 2 diabetes. Researchers will compare the digital versions of three common physical tests (6-minute walk, timed up and go, and sit-to-stand) with the traditional versions. If the mixed reality tests prove accurate, they could offer a more convenient and standardized way to monitor patients, possibly even from home.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mixed reality-based functional performance assessment using Meta Quest 3
What this could lead to
If successful, this could provide a more standardized, digital way to assess mobility and function in people with type 2 diabetes, potentially enabling remote monitoring.
What could go wrong
This is a small, early-stage validation study (75 participants) focused on measurement accuracy, not treatment. The technology may not work well for all patients or replace traditional tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 75 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults aged 18-65 years diagnosed with Type 2 Diabetes Mellitus who are able to ambulate independently, are clinically stable, and are eligible to participate in conventional and mixed reality-based functional performance assessments.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with Type 2 Diabetes Mellitus by a physician, * Aged between 18 and 65 years, * Ability to ambulate independently without the use of an assistive device, * No participation in a structured exercise program within the previous 6 months, * Cognitive ability sufficient to understand and follow test instructions, * Visual, auditory, and vestibular functions sufficient to tolerate mixed reality applications, * Ability to read, understand, and follow instructions in Turkish, * Willingness to participate voluntarily in the study and provision of written informed consent. Exclusion Criteria: * Presence of proliferative diabetic retinopathy or severe non-proliferative diabetic retinopathy, * Advanced peripheral neuropathy, active foot ulcer, Charcot foot, or significant sensory loss that may compromise safe test performance, * Presence of peripheral arterial disease, * Advanced renal failure, requirement for dialysis, or nephropathy that may compromise exercise safety, * Myocardial infarction within the previous 6 months, * Unstable ischemic heart disease or uncontrolled angina, * Resting blood pressure greater than 160/100 mmHg, * Presence of severe musculoskeletal, neurological, or vestibular disorders that may interfere with safe test performance, * High risk of balance loss or spatial disorientation in the mixed reality environment due to visual, auditory, or balance impairments, * Cognitive, behavioral, or compliance-related problems that may prevent completion of the study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes mellitus (T2DM) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes mellitus (T2DM)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

    RECRUITING

    Konya, Selcuklu, 42130, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.